Stock Markets March 2, 2026

Madrid Stocks Retreat; IBEX 35 Drops 2.62% as Consumer and Financial Names Lead Declines

Repsol climbs to five-year highs while major banks and retailers post sizable losses; oil and gold move higher

By Maya Rios SAN
Madrid Stocks Retreat; IBEX 35 Drops 2.62% as Consumer and Financial Names Lead Declines
SAN

Spain's benchmark index finished lower on Monday, with the IBEX 35 closing down 2.62% as weakness in the Consumer Goods, Financial Services & Real Estate and Consumer Services sectors weighed on the market. While Repsol surged, several large-cap names including Industria de Diseno Textil SA and Banco Santander posted sharp declines. Commodities and the dollar saw notable moves during the session.

Key Points

  • IBEX 35 closed down 2.62% as losses in Consumer Goods, Financial Services & Real Estate, and Consumer Services drove the market lower.
  • Top gainers included Repsol (up 5.60% to 20.08), Naturgy (up 1.37% to 26.70), and Cellnex (up 1.06% to 32.48); Repsol reached a five-year high.
  • Major decliners were Industria de Diseno Textil SA (down 4.86% to 54.06), Banco Santander (down 4.84% to 10.27), and International Consolidated Airlines Group (down 4.72% to 4.60).

Spanish equities ended the trading day in Madrid on negative footing, with the IBEX 35 slipping 2.62% at the close. Selling pressure was concentrated in Consumer Goods, Financial Services & Real Estate and Consumer Services, driving the broad decline.

On the winners' side, Repsol (BME:REP) outperformed, rising 5.60% or 1.07 points to finish at 20.08, a move that took the stock to five-year highs. Naturgy Energy Group SA (BME:NTGY) added 1.37% or 0.36 points to close at 26.70, while Cellnex Telecom SA (BME:CLNX) gained 1.06% or 0.34 points to end the session at 32.48.

By contrast, some of the market's largest declines came from retail and banking names. Industria de Diseno Textil SA (BME:ITX) fell 4.86% or 2.76 points to 54.06 at the close. Banco Santander (BME:SAN) dropped 4.84% or 0.52 points to 10.27, and International Consolidated Airlines Group S.A. (BME:ICAG) lost 4.72% or 0.23 points to trade at 4.60.

Market breadth in Madrid was negative, with 168 stocks closing lower versus 34 that advanced, and 12 that finished unchanged.

Commodity markets were active during the session. April Gold Futures rose 1.29% or 67.71 to $5,315.61 a troy ounce. In energy, April crude oil climbed 5.51% or 3.69 to $70.71 a barrel, and the May Brent contract increased 6.04% or 4.40 to trade at $77.27 a barrel.

Currency moves accompanied the market action. The euro-dollar pair (EUR/USD) was down 1.00% to 1.17, while EUR/GBP was reported unchanged 0.38% to 0.87. The US Dollar Index Futures rose 0.98% to 98.52.


Market context and tools

Investors considering opportunities for 2026 may look to data-driven research to inform decisions. The view presented here highlights that improved data and analytics can supplement investor judgment; institutional-grade data and AI-supported insights are cited as tools that may help identify opportunities more consistently, though they do not guarantee success.

Risks

  • Sector concentration risk: Consumer Goods, Financial Services & Real Estate, and Consumer Services led the decline, indicating sector-specific pressure that could amplify market volatility.
  • Commodity price swings: Significant moves in crude oil and Brent prices during the session may affect energy and industrial companies' earnings and valuations.
  • Currency volatility: A 1.00% fall in EUR/USD and a stronger US Dollar Index Futures reading (up 0.98% to 98.52) introduce FX-related risks for exporters and multinational firms.

More from Stock Markets

Dining Out Drives Job Gains as Consumers Seek Affordable Treats Mar 2, 2026 Dimon Says AI Could Trim the Work Week as Banks Embrace New Tools Mar 2, 2026 Exelixis Shares Drop After Merck Combo Therapy Outperforms Cabometyx in Late-Stage Trial Mar 2, 2026 Restaurant Brands outlines franchise-first strategy and Burger King operational push to lift growth Mar 2, 2026 Aardvark Therapeutics Pauses Phase 3 HERO Trial After Cardiac Signals; Shares Collapse Mar 2, 2026